Crossmark

Beta 2 adrenergic receptor and mu opioid receptor interact to potentiate the aggressiveness of human breast cancer cell by activating the glycogen synthase kinase 3 signaling

Crossref DOI link: https://doi.org/10.1186/s13058-022-01526-y

Published Online: 2022-05-14

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rousseau, Bénédicte

Murugan, Sengottuvelan

Palagani, Ajay

Sarkar, Dipak K.
Funding

Funding for this research was provided by:

National Institutes of Health (R01 CA208632)
License Information

Text and Data Mining valid from 2022-05-14

Version of Record valid from 2022-05-14
More Information

Article History

Received: 7 December 2021

Accepted: 20 April 2022

First Online: 14 May 2022

Declarations

:

: All animal care and procedures were approved by the Rutgers Institutional Animal Care and Facilities Committee (PROTO 999900286) and complied with National Institutes of Health policy.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below